Company news

Share this article:
MANUFACTURER NEWS
Astellas Pharma Technologies is offering early retirement to 200 workers at its Norman, OK, plant. The cuts anticipate the patent expiration Flomax.
 
Merck KGaA, the German manufacturer of Erbitux cancer treatment, has announced a partnership with Belgian biotech Ablynx NV to develop tumor and immune disorder treatments. 
 
 
AGENCY NEWS
Concentric Pharma Advertising has won an AOR assignment on Surfaxin, an investigational respiratory distress syndrome (RDS) treatment manufactured by Discovery Labs.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.